课题基金 / 基金详情

Clinicopathologic, molecular pathologic and biologic study of malignant lymphoma

Clinicopathologic, molecular pathologic and biologic study of malignant lymphoma
恶性淋巴瘤的临床病理学、分子病理学和生物学研究
批准号:
06670211
负责人:
NAKAMURA Shigeo
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKAMURA Shigeo的其他基金

相似基金

相关文献

中文摘要
翻译
对套细胞淋巴瘤(MCL)、原发胃B细胞淋巴瘤(PGL)、CD56(NCAM)阳性的血管中心性淋巴瘤(ACL)和鼻腔T/NK细胞淋巴瘤(NTCL)的临床病理、分子病理学和生物学特性进行了研究。我们制备了一种针对重组PRAD1/细胞周期蛋白D1产物的单抗5D4,结果表明,细胞周期蛋白D1蛋白的免疫定位是诊断恶性淋巴瘤的重要指标。我们根据粘膜相关淋巴组织低度B细胞淋巴瘤(MALT)的概念提出的PGL的组织学分型与生长形态、病理分期、预后以及BC12和p53等癌基因的表达有关。在爱知癌症中心的登记病例中,也发现了10例CD56阳性的ACL患者,构成了一个独特的组,其特点是血管中心性、嗜天青颗粒、假定的自然杀伤(NK)细胞系和侵袭性行为。此外,本研究支持NTCL是一种与其他T细胞淋巴瘤不同的EB病毒相关肿瘤。这些数据可能为阐明日本人恶性淋巴瘤的疾病谱提供依据。在这项研究的过程中,也强调了位于灰区的淋巴增生性疾病的进一步调查。
英文摘要
Several entities of non-Hodgkin's lymphoma, i.e., mantle cell lymphoma (MCL), primary gastric B-cell lymphoma (PGL), CD56 (NCAM) -positive angiocentric lymphoma (AcL), and nasal T/NK-cell lymphomas (NTCL), were investigated on their clinicopathologic, molecular pathologic and biologic aspects. We produced a monoclonal antibody, 5D4, against a recombinant PRAD1/cyclin D1 product, and revealed that the immunolocalization of cyclin D1 protein is an essential marker for the definite diagnosis of MCL.The patients with cyclin D1 overexpressing lymphomas appeared to consitute a very homogeneous group, the 5-year survival rate being 11%. The histological typing of PGL,which was proposed by us on the basis of the concept of low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), showed to correlate with growth appearance, pathologic stage, prognosis, and expression of several oncogenes such as bc12 and p53.10 patients with CD56-positive AcLs were also identified among the registered cases in Aichi Cancer Center, constituting a distinct group characterized by angiocentricity, azurophilic granules, putative natural killer (NK) -cell lineage, and aggressive behavior. Furthermore, the present study supported that NTCL is identified as Epstein-Barr virus-associated tumors distinct from the other T-cell lymphoma. These date may provide the basis for clarifying the disease spectrum of malignant lymphomas in the Japanese patients. During the process of this study, further investigation of lymphoproliferative disorders located at the gray zone was also emphasized.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
Suchi T, et al.: "Primary gastric lymphoma of B-cell phenotype with special reference to low-grade B-cell lymphoma of mucosa-associated..." Med J Kagoshima Univ. 47. 43-52 (1995)
Suchi T 等人:“B 细胞表型的原发性胃淋巴瘤,特别是粘膜相关的低度 B 细胞淋巴瘤……”Med J Kagoshima Univ。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kojima M,et al.: "Primary malignant lymphoma of the intestine:Clinico-pathologic and immunohistochemical studies of 39 cases." Pathol Int. 45. 123-130 (1995)
Kojima M,et al.:“原发性肠道恶性淋巴瘤:39 例临床病理和免疫组织化学研究。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakamura S,et al.: "Interdigitating cell sarcoma.A morphologic and immunologic study of lymph node lesion of four cases." Pathol Int. 44. 374-386 (1994)
Nakamura S,et al.:“叉指细胞肉瘤。四例淋巴结病变的形态学和免疫学研究。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 33 条
    Clinicopathologic and biologic study oriented for the new classification of EBV-associated lymphoproliferative disorder
    • 批准号:
      19590344
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位:
    Clinicopathologic and molecular biological study of senile/age-related EBV-associated B-cell
    Clinicopathologic and molecular biologic analyses for recognizing newly-defined adult lymphoma entities.
    • 批准号:
      14570175
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位:
    悪性リンパ腫におけるMALT1とAPI2遺伝子発現の意義の病理学的、生物学的研究
    • 批准号:
      12670191
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位:
    海外基金